Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorChoon Hyuck David Kwon

About this trial

The goal of this single armed, non-randomized, pilot study is to demonstrate that placental tissue grafts are safe in living donor liver transplant and assess their impact on biliary outcomes in adults.

Eligibility criteria

Qualifiers

Adults >/= 18 years old

Recipient of LDLT

Disqualifiers

Patients who are deemed unsafe for participation for any reason by our multi-disciplinary liver transplant selection committee.

Patients < 18 years old

Patients who cannot provide informed consent

Patients receiving deceased donor liver transplants, or who are not undergoing Liver transplant (LT)

Trial design

Treatments tested in this trial

  • MiMedx AmnioFix

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators

Choon Hyuck David Kwon

Lead sponsor

The Cleveland Clinic

Sponsor institution